Masimo (MASI) announced a multi-year renewal and expansion of its strategic partnership with Royal Philips (PHG). This partnership expansion is designed to accelerate the integration of Masimo’s monitoring technologies, such as SET pulse oximetry, into a variety of Philips multi-parameter patient monitors through 2026 and beyond. This includes integrating Masimo’s Radius PPG with Masimo-board equipped Philips monitors and next-generation wearable multi-parameter solutions, as well as integrating a range of Masimo sensor technology with all Masimo-equipped Philips bedside monitors and central stations. Philips and Masimo will also work together to strategically develop, produce, and co-promote next-generation artificial intelligence-based monitoring technologies.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASI:
- Walmart reports mixed Q2, Thoma Bravo to acquire Dayforce: Morning Buzz
- Masimo sues U.S. CBP over allowing Apple to reactivate feature, Bloomberg says
- Masimo Board Member William Jellison Resigns
- Masimo O3 Regional Oximetry receives FDA clearance for expanded indication
- Video: Why Masimo Is Sliding Today